Literature DB >> 9029350

Immunomodulatory activity of beta-casein permeate medium fermented by lactic acid bacteria.

E Laffineur1, N Genetet, J Leonil.   

Abstract

During fermentation, lactic acid bacteria may be able to release components that possess immunomodulatory activity. This activity was investigated in several culture supernatants arising from lactic acid bacteria cultured in a medium composed primarily of UF permeate of bovine milk; beta-CN was added as the sole protein source. Only a Lactobacillus helveticus supernatant allowed the modulation (both suppression and enhancement) of lymphocyte proliferation in vitro on human peripheral blood lymphocytes, but L. helveticus did not modulate the cytotoxic activity of natural killer cells or of lymphokine-activated killer cells. The addition of different quantities of culture supernatant to cultures of human mononuclear cells, stimulated by the mitogen concanavalin A, significantly increased the production of interferon-gamma and decreased the production of interleukin-2 and the expression of the alpha-chain of the interleukin-2 receptor (p55), all of which appear to be correlated with the decrease in lymphocyte proliferation. Our results suggest that the culture supernatant activity might be related to interaction with monocyte-macrophage and T helper cells, especially Th1-like cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029350     DOI: 10.3168/jds.S0022-0302(96)76585-2

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  11 in total

1.  Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

Authors:  K Robinson; L M Chamberlain; M C Lopez; C M Rush; H Marcotte; R W F Le Page; J M Wells
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 2.  Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.

Authors:  Simone Marcone; Orina Belton; Desmond J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

3.  Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk.

Authors:  Jason Leblanc; Ismail Fliss; Chantal Matar
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Health-Promoting Properties of Lactobacillus helveticus.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Front Microbiol       Date:  2012-11-19       Impact factor: 5.640

5.  Lactobacillus helveticus: the proteolytic system.

Authors:  M W Griffiths; A M Tellez
Journal:  Front Microbiol       Date:  2013-03-05       Impact factor: 5.640

6.  Complete Genome Sequence for Lactobacillus helveticus CNRZ 32, an Industrial Cheese Starter and Cheese Flavor Adjunct.

Authors:  Jeff R Broadbent; Joanne E Hughes; Dennis L Welker; Thomas A Tompkins; James L Steele
Journal:  Genome Announc       Date:  2013-08-22

7.  Genome sequence and analysis of Lactobacillus helveticus.

Authors:  Paola Cremonesi; Stefania Chessa; Bianca Castiglioni
Journal:  Front Microbiol       Date:  2013-01-11       Impact factor: 5.640

8.  Milk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity.

Authors:  Gabriel Vinderola; Chantal Matar; Gabriela Perdigón
Journal:  BMC Immunol       Date:  2007-09-07       Impact factor: 3.615

Review 9.  Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines.

Authors:  Enrica Pessione; Simona Cirrincione
Journal:  Front Microbiol       Date:  2016-06-09       Impact factor: 5.640

Review 10.  Casein and Peptides Derived from Casein as Antileukaemic Agents.

Authors:  Edgar Ledesma-Martínez; Itzen Aguíñiga-Sánchez; Benny Weiss-Steider; Ana Rocío Rivera-Martínez; Edelmiro Santiago-Osorio
Journal:  J Oncol       Date:  2019-09-08       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.